PRISMMEDI
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Prism Medico And Pharmacy Approves Issuance Of 7.5 Million Shares And 5 Million Warrants
Feb 23 (Reuters) - Prism Medico and Pharmacy Ltd PRIE.BO:
APPROVES ISSUANCE OF 7.5 MILLION SHARES AND 5 MILLION WARRANTS
ISSUE PRICE SET AT 20 RUPEES PER SHARE, WARRANT
Source text: ID:nBSE424LGq
Further company coverage: PRIE.BO
(([email protected];;))
Feb 23 (Reuters) - Prism Medico and Pharmacy Ltd PRIE.BO:
APPROVES ISSUANCE OF 7.5 MILLION SHARES AND 5 MILLION WARRANTS
ISSUE PRICE SET AT 20 RUPEES PER SHARE, WARRANT
Source text: ID:nBSE424LGq
Further company coverage: PRIE.BO
(([email protected];;))
Prism Medico And Pharmacy To Consider Fund Raising Via Preferential Issue
Feb 18 (Reuters) - Prism Medico and Pharmacy Ltd PRIE.BO:
TO CONSIDER FUND RAISING VIA PREFERENTIAL ISSUE
Source text: ID:nBSE3FMmxP
Further company coverage: PRIE.BO
(([email protected];))
Feb 18 (Reuters) - Prism Medico and Pharmacy Ltd PRIE.BO:
TO CONSIDER FUND RAISING VIA PREFERENTIAL ISSUE
Source text: ID:nBSE3FMmxP
Further company coverage: PRIE.BO
(([email protected];))
Prism Medico And Pharmacy Appointed Bharat Singh As CFO
May 16 (Reuters) - Prism Medico and Pharmacy Ltd PRIE.BO:
APPOINTED BHARAT SINGH AS CFO
CFO GURSIMRAN SINGH RESIGNS
Source text for Eikon: ID:nBSE97Vy8k
Further company coverage: PRIE.BO
(([email protected];))
May 16 (Reuters) - Prism Medico and Pharmacy Ltd PRIE.BO:
APPOINTED BHARAT SINGH AS CFO
CFO GURSIMRAN SINGH RESIGNS
Source text for Eikon: ID:nBSE97Vy8k
Further company coverage: PRIE.BO
(([email protected];))
Events:
More Nano Cap Ideas
See similar 'Nano' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Prism Medico do?
Prism Medico and Pharmacy Ltd is a company specializing in trading goods and commodities along with investing in shares, securities, and financing activities in the healthcare and pharmaceutical domain.
Who are the competitors of Prism Medico?
Prism Medico major competitors are Bharat Bhushan Fin., Photon Capital Advis, Jolly Plastic, Blue Chip India, Decillion Finance, Bazel International, Shree Securities. Market Cap of Prism Medico is ₹17 Crs. While the median market cap of its peers are ₹17 Crs.
Is Prism Medico financially stable compared to its competitors?
Prism Medico seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does Prism Medico pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Prism Medico latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Prism Medico allocated its funds?
Companies resources are allocated to majorly unproductive assets like Short Term Loans & Advances
How strong is Prism Medico balance sheet?
Balance sheet of Prism Medico is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Prism Medico improving?
The profit is oscillating. The profit of Prism Medico is ₹0.6 Crs for TTM, -₹0.05 Crs for Mar 2025 and -₹0.02 Crs for Mar 2024.
Is the debt of Prism Medico increasing or decreasing?
Yes, The net debt of Prism Medico is increasing. Latest net debt of Prism Medico is -₹0.11 Crs as of Mar-25. This is greater than Mar-24 when it was -₹0.12 Crs.
Is Prism Medico stock expensive?
Prism Medico is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE. Latest PE of Prism Medico is 27.65, while 3 year average PE is 29.17. Also latest EV/EBITDA of Prism Medico is 31.01 while 3yr average is 20.91.
Has the share price of Prism Medico grown faster than its competition?
Prism Medico has given better returns compared to its competitors. Prism Medico has grown at ~35.99% over the last 4yrs while peers have grown at a median rate of 12.15%
Is the promoter bullish about Prism Medico?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Prism Medico is 25.0% and last quarter promoter holding is 25.0%.
Are mutual funds buying/selling Prism Medico?
There is Insufficient data to gauge this.
